🚀 VC round data is live in beta, check it out!
Seer Valuation Multiples
Discover revenue and EBITDA valuation multiples for Seer and similar public comparables like Definitive Healthcare, Revium Recovery, Health Catalyst, Senzime and more.
Seer Overview
About Seer
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Founded
2017
HQ
Employees
134
Website
Financials (LTM)
Market Cap
$113M
Seer Financials
Seer reported last 12-month revenue of $17M.
In the same LTM period, Seer generated $8M in gross profit and had net loss of ($70M).
Revenue (LTM)
Seer P&L
In the most recent fiscal year, Seer reported revenue of $17M and EBITDA of ($72M).
Seer expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $17M | XXX | $17M | XXX | XXX | XXX |
| Gross Profit | $8M | XXX | $8M | XXX | XXX | XXX |
| Gross Margin | 51% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($72M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (434%) | XXX | XXX | XXX |
| EBIT Margin | (443%) | XXX | (470%) | XXX | XXX | XXX |
| Net Profit | ($70M) | XXX | ($74M) | XXX | XXX | XXX |
| Net Margin | (420%) | XXX | (444%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Seer Stock Performance
Seer has current market cap of $113M.
Market Cap Evolution
Seer's stock price is $2.01.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $113M | -2.0% | XXX | XXX | XXX | $-1.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSeer Valuation Multiples
Seer trades at (2.9x) EV/Revenue multiple, and 0.7x EV/EBITDA.
EV / Revenue (LTM)
Seer Financial Valuation Multiples
As of April 19, 2026, Seer has market cap of $113M.
Equity research analysts estimate Seer's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Seer has a P/E ratio of (1.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $113M | XXX | $113M | XXX | XXX | XXX |
| EV (current) | ($49M) | XXX | ($49M) | XXX | XXX | XXX |
| EV/Revenue | (2.9x) | XXX | (2.9x) | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBIT | 0.7x | XXX | 0.6x | XXX | XXX | XXX |
| EV/Gross Profit | (5.8x) | XXX | (6.1x) | XXX | XXX | XXX |
| P/E | (1.6x) | XXX | (1.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 1.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Seer Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Seer Margins & Growth Rates
Seer's revenue in the last 12 month grew by 8%.
Seer's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.6M for the same period.
Seer Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (434%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (23%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 253% | XXX | 265% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 519% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Seer Public Comps
See public comps and valuation multiples for other Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Seer | XXX | XXX | XXX | XXX | XXX | XXX |
| Definitive Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Revium Recovery | XXX | XXX | XXX | XXX | XXX | XXX |
| Health Catalyst | XXX | XXX | XXX | XXX | XXX | XXX |
| Senzime | XXX | XXX | XXX | XXX | XXX | XXX |
| OptimizeRx | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Seer M&A Activity
Seer acquired XXX companies to date.
Last acquisition by Seer was on XXXXXXXX, XXXXX. Seer acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Seer
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSeer Investment Activity
Seer invested in XXX companies to date.
Seer made its latest investment on XXXXXXXX, XXXXX. Seer invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Seer
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Seer
| When was Seer founded? | Seer was founded in 2017. |
| Where is Seer headquartered? | Seer is headquartered in United States. |
| How many employees does Seer have? | As of today, Seer has over 134 employees. |
| Who is the CEO of Seer? | Seer's CEO is Omid Farokhzad. |
| Is Seer publicly listed? | Yes, Seer is a public company listed on Nasdaq. |
| What is the stock symbol of Seer? | Seer trades under SEER ticker. |
| When did Seer go public? | Seer went public in 2020. |
| Who are competitors of Seer? | Seer main competitors are Definitive Healthcare, Revium Recovery, Health Catalyst, Senzime. |
| What is the current market cap of Seer? | Seer's current market cap is $113M. |
| What is the current revenue of Seer? | Seer's last 12 months revenue is $17M. |
| What is the current revenue growth of Seer? | Seer revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Seer? | Current revenue multiple of Seer is (2.9x). |
| Is Seer profitable? | No, Seer is not profitable. |
| What is the current net income of Seer? | Seer's last 12 months net income is ($70M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.